BioActives and Maypro Launch Sustained-Release MicroActive Curcumin-SR
Known for its chemo-preventative, anti-inflammatory and anti-arthritic properties, curcumin is being recognized for its significant health and healing benefits.
Nov 4 2010 --- BioActives LLC and Maypro Industries launched Sustained Release MicroActive Curcuminas a micronized multi-stage time-release curcumin.
Developed by Bioactives as a more bioavailable curcumin formulation MicroActive Curcumin-SR solubilizes curcuminoids thereby greatly reducing particle size. A portion of the micronized particles are then encapsulated creating a formulated ingredient that releases in the stomach bile acid and then in the higher pH small intestines. MicroActive Curcumin-SR will be distributed by Maypro Industries..
Known for its chemo-preventative, anti-inflammatory and anti-arthritic properties, curcumin is being recognized for its significant health and healing benefits. “We therefore believe that MicroActive Curcumin-SR will prove to be a valuable product for healthcare practitioners and consumers alike”, says Dan Kagan PhD, managing partner at BioActives. He also notes that the sustained release form can be combined with standard curcumin for more precise cost-benefit formulations.
MicroActive Curcumin-SR will be distributed by Maypro Industries and marketed worldwide. This distribution partnership builds on the previous collaboration between Bioactives and Maypro to bring to market patented, highly bioavailable, sustained release and universally absorbed ingredients. “MicroActive Curcumin-SR will enable our customers to launch unique value -added products while leveraging the significant growth of the curcumin market.”, says Dan Lifton, Vice-President of Business Development at Maypro.
